Dechra Pharmaceuticals plc Company Profile (LON:DPH)

About Dechra Pharmaceuticals plc (LON:DPH)

Dechra Pharmaceuticals plc logoDechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The Company is engaged in development, manufacture and marketing of products for veterinarians. Its segments include European Pharmaceuticals, North American (NA) Pharmaceuticals and Pharmaceuticals Research and Development. The European Pharmaceuticals Segment includes Dechra Veterinary Products Europe, Genera and Dechra Pharmaceuticals Manufacturing. It manufactures and markets Companion Animal, Equine and Food producing Animal Products. It includes third party manufacturing and other non-core activities sales. The NA Pharmaceuticals Segment consists of Dechra Veterinary Products US, Putney, Dechra Veterinary Products Canada, and Dechra-Brovel that sell Companion Animal and Equine Products into those territories. The Pharmaceuticals Research and Development Segment includes its pharmaceutical research and development activities. Its offerings include Osphos and Vetoryl.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:DPH
  • CUSIP: N/A
  • Web: N/A
  • Market Cap: £1.7 billion
  • Outstanding Shares: 92,818,000
Average Prices:
  • 50 Day Moving Avg: GBX 1,713.43
  • 200 Day Moving Avg: GBX 1,511.30
  • 52 Week Range: GBX 811 - GBX 1,851
  • Trailing P/E Ratio: 120.00
  • P/E Growth: 1.65
Sales & Book Value:
  • Annual Revenue: £309.39 million
  • Price / Sales: 5.51
  • Book Value: GBX 3.08 per share
  • Price / Book: 5.96
  • EBIDTA: £62.2 million
  • Average Volume: 161,947 shs.

Frequently Asked Questions for Dechra Pharmaceuticals plc (LON:DPH)

What is Dechra Pharmaceuticals plc's stock symbol?

Dechra Pharmaceuticals plc trades on the London Stock Exchange (LON) under the ticker symbol "DPH."

How often does Dechra Pharmaceuticals plc pay dividends? What is the dividend yield for Dechra Pharmaceuticals plc?

Dechra Pharmaceuticals plc declared a dividend on Monday, February 27th. Investors of record on Thursday, March 9th will be given a dividend of GBX 6.11 per share on Friday, April 7th. This represents a dividend yield of 0.38%. The ex-dividend date of this dividend is Thursday, March 9th. The official announcement can be seen at this link. View Dechra Pharmaceuticals plc's Dividend History.

Where is Dechra Pharmaceuticals plc's stock going? Where will Dechra Pharmaceuticals plc's stock price be in 2017?

6 brokerages have issued twelve-month price objectives for Dechra Pharmaceuticals plc's stock. Their predictions range from GBX 1,140 to GBX 1,890. On average, they expect Dechra Pharmaceuticals plc's stock price to reach GBX 1,576.43 in the next twelve months. View Analyst Ratings for Dechra Pharmaceuticals plc.

Who are some of Dechra Pharmaceuticals plc's key competitors?

How do I buy Dechra Pharmaceuticals plc stock?

Shares of Dechra Pharmaceuticals plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Dechra Pharmaceuticals plc stock cost?

One share of Dechra Pharmaceuticals plc stock can currently be purchased for approximately GBX 1,836.

Analyst Ratings

Consensus Ratings for Dechra Pharmaceuticals plc (LON:DPH) (?)
Ratings Breakdown: 3 Hold Ratings, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 1,576.43

Analysts' Ratings History for Dechra Pharmaceuticals plc (LON:DPH)
DateFirmActionRatingPrice TargetDetails
4/20/2017Panmure GordonReiterated RatingUnder ReviewView Rating Details
4/4/2017Numis Securities LtdBoost Price TargetAddGBX 1,700 -> GBX 1,890View Rating Details
4/4/2017Stifel NicolausBoost Price TargetHoldGBX 1,440 -> GBX 1,550View Rating Details
3/14/2017Royal Bank of CanadaBoost Price TargetOutperformGBX 1,630 -> GBX 1,890View Rating Details
3/1/2017Jefferies Group LLCBoost Price TargetHoldGBX 1,320 -> GBX 1,565View Rating Details
2/27/2017N+1 SingerReiterated RatingBuyGBX 1,600View Rating Details
2/24/2017FinnCapReiterated RatingUnder ReviewView Rating Details
9/5/2016InvestecBoost Price TargetBuyGBX 1,300 -> GBX 1,400View Rating Details
9/7/2015Shore CapitalReiterated RatingBuyView Rating Details
(Data available from 5/24/2015 forward)


Earnings History for Dechra Pharmaceuticals plc (LON:DPH)
No earnings announcements for this company have been tracked by


Earnings Estimates for Dechra Pharmaceuticals plc (LON:DPH)
Current Year EPS Consensus Estimate: $62.33 EPS


Dividend History by Quarter for Dechra Pharmaceuticals plc (LON:DPH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/27/2017GBX 6.110.38%3/9/20173/9/20174/7/2017
9/5/2016GBX 12.910.92%10/27/201610/27/201611/18/2016
2/22/2016GBX 5.550.47%3/10/20163/10/20164/6/2016
9/7/2015GBX 11.821.26%10/29/201510/29/201511/20/2015
9/8/2014GBX 10.651.4%11/6/201411/6/201411/21/2014
2/25/2014GBX 4.750.68%3/12/20143/12/20144/8/2014
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Dechra Pharmaceuticals plc (LON:DPH)
Insider Trades by Quarter for Dechra Pharmaceuticals plc (LON:DPH)
Insider Trades by Quarter for Dechra Pharmaceuticals plc (LON:DPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/2/2017Ian PageInsiderSell1,630GBX 1,715£27,954.50
3/21/2017Tony GriffinInsiderSell3,500GBX 1,676£58,660
11/30/2016Tony GriffinInsiderSell17,133GBX 1,292£221,358.36
6/3/2016Rice,TonyInsiderBuy20,000GBX 1,141£228,200
3/21/2016Nesmes,Anne-FrancoiseInsiderSell3,100GBX 1,208£37,448
9/9/2015Nesmes,Anne-FrancoiseÂInsiderSell18,319GBX 940£172,198.60
(Data available from 1/1/2013 forward)


Headline Trends for Dechra Pharmaceuticals plc (LON:DPH)
Latest Headlines for Dechra Pharmaceuticals plc (LON:DPH)
DateHeadline logoDechra Pharmaceuticals plc (DPH) Given Consensus Recommendation of "Buy" by Analysts - May 19 at 12:54 PM logoDechra Pharmaceuticals plc (DPH) Insider Ian Page Sells 1,630 Shares - May 6 at 12:20 AM logoDechra Pharmaceuticals plc (DPH) Insider Sells £27,954.50 in Stock - May 4 at 7:06 AM logoDechra Pharmaceuticals plc (DPH) Given Average Rating of "Buy" by Brokerages - April 24 at 2:56 PM logoDechra Pharmaceuticals plc (DPH) Receives "Under Review" Rating from Panmure Gordon - April 20 at 7:37 PM logoDechra Pharmaceuticals Plc – Value Analysis (LONDON:DPH) : April 20, 2017 - April 20 at 4:53 PM logoDechra Pharmaceuticals Plc breached its 50 day moving average in a Bearish Manner : DPH-GB : April 19, 2017 - April 19 at 12:28 PM logoDechra Pharmaceuticals plc (DPH) Price Target Raised to GBX 1,550 - April 8 at 6:09 PM logoDechra Pharmaceuticals Plc : DPH-GB: Dividend Analysis : March 10th, 2017 (record date) : By the numbers : April 4, 2017 - April 7 at 9:28 AM logoDechra Pharmaceuticals plc (DPH) Given Average Recommendation of "Buy" by Brokerages - March 29 at 2:49 PM logoInsider Selling: Dechra Pharmaceuticals plc (DPH) Insider Sells 3,500 Shares of Stock - March 23 at 4:28 AM logoDechra Pharmaceuticals plc (DPH) Given Add Rating at Numis Securities Ltd - March 20 at 12:27 AM logoDechra® Pharmaceuticals PLC (LSE symbol DPH) Releases its 2017 Half-yearly Financial Report - PR Newswire (press release) - February 28 at 8:12 AM logoDechra® Pharmaceuticals PLC (LSE symbol DPH) Releases its 2017 Half-yearly Financial Report - February 27 at 7:36 PM logoHalf Year 2017 Dechra Pharmaceuticals PLC Earnings Release - Before Market Open - February 27 at 7:36 PM logoWhy I’m avoiding these exciting growth shares right now - February 16 at 2:55 PM logoShould you make room for Pets At Home Group plc after today's update? - Yahoo Finance UK - January 19 at 11:07 PM logoShould you make room for Pets At Home Group plc after today’s update? - January 19 at 6:06 PM logoDoes this pharma's 56% sales growth make it a better buy than GlaxoSmithKline plc? - Yahoo Finance UK - January 17 at 8:22 AM logoDechra® Pharmaceuticals PLC Trading Update - January 17 at 8:22 AM logoDoes this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc? - January 17 at 8:22 AM logoCould these top-performing stocks be about to collapse? - November 7 at 5:46 AM logoAre These Pharma Fizzers 'Hot Buys' After Today's News? - October 21 at 4:44 PM


Social activity is not available for this stock.


Dechra Pharmaceuticals plc (DPH) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by Staff